These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 34007201)
1. MCTR1 Intervention Reverses Experimental Lung Fibrosis in Mice. Pan J; Li X; Wang X; Yang L; Chen H; Su N; Wu C; Hao Y; Jin S; Li H J Inflamm Res; 2021; 14():1873-1881. PubMed ID: 34007201 [TBL] [Abstract][Full Text] [Related]
2. GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition. Zhou XM; Wang GL; Wang XB; Liu L; Zhang Q; Yin Y; Wang QY; Kang J; Hou G Front Pharmacol; 2017; 8():904. PubMed ID: 29311918 [No Abstract] [Full Text] [Related]
3. Induced Pluripotent Stem Cells Inhibit Bleomycin-Induced Pulmonary Fibrosis in Mice through Suppressing TGF-β1/Smad-Mediated Epithelial to Mesenchymal Transition. Zhou Y; He Z; Gao Y; Zheng R; Zhang X; Zhao L; Tan M Front Pharmacol; 2016; 7():430. PubMed ID: 27895584 [TBL] [Abstract][Full Text] [Related]
4. MCTR1 alleviates lipopolysaccharide-induced acute lung injury by protecting lung endothelial glycocalyx. Li H; Hao Y; Yang LL; Wang XY; Li XY; Bhandari S; Han J; Liu YJ; Gong YQ; Scott A; Smith FG; Jin SW J Cell Physiol; 2020 Oct; 235(10):7283-7294. PubMed ID: 32037554 [TBL] [Abstract][Full Text] [Related]
5. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition. Gao L; Jiang D; Geng J; Dong R; Dai H Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412 [TBL] [Abstract][Full Text] [Related]
6. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658 [TBL] [Abstract][Full Text] [Related]
7. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways. Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714 [TBL] [Abstract][Full Text] [Related]
8. Protective effects of Qing-Re-Huo-Xue formula on bleomycin-induced pulmonary fibrosis through the p53/IGFBP3 pathway. Yang F; Du W; Tang Z; Wei Y; Dong J Chin Med; 2023 Mar; 18(1):33. PubMed ID: 36997948 [TBL] [Abstract][Full Text] [Related]
9. Posttreatment with Protectin DX ameliorates bleomycin-induced pulmonary fibrosis and lung dysfunction in mice. Li H; Hao Y; Zhang H; Ying W; Li D; Ge Y; Ying B; Cheng B; Lian Q; Jin S Sci Rep; 2017 May; 7():46754. PubMed ID: 28466866 [TBL] [Abstract][Full Text] [Related]
10. Maresin conjugates in tissue regeneration 1 prevents lipopolysaccharide-induced cardiac dysfunction through improvement of mitochondrial biogenesis and function. Yang Y; Zhu Y; Xiao J; Tian Y; Ma M; Li X; Li L; Zhang P; Li M; Wang J; Jin S Biochem Pharmacol; 2020 Jul; 177():114005. PubMed ID: 32360364 [TBL] [Abstract][Full Text] [Related]
11. Maresin Conjugates in Tissue Regeneration 1 improves alveolar fluid clearance by up-regulating alveolar ENaC, Na, K-ATPase in lipopolysaccharide-induced acute lung injury. Han J; Li H; Bhandari S; Cao F; Wang XY; Tian C; Li XY; Zhang PH; Liu YJ; Wu CH; Smith FG; Jin SW; Hao Y J Cell Mol Med; 2020 Apr; 24(8):4736-4747. PubMed ID: 32160403 [TBL] [Abstract][Full Text] [Related]
12. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways. Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203 [TBL] [Abstract][Full Text] [Related]
13. Oropharyngeal aspiration of bleomycin: An alternative experimental model of pulmonary fibrosis developed in Swiss mice. Bale S; Sunkoju M; Reddy SS; Swamy V; Godugu C Indian J Pharmacol; 2016; 48(6):643-648. PubMed ID: 28066100 [TBL] [Abstract][Full Text] [Related]
14. Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis. Tong B; Fu L; Hu B; Zhang ZC; Tan ZX; Li SR; Chen YH; Zhang C; Wang H; Xu DX; Zhao H BMC Pulm Med; 2021 May; 21(1):149. PubMed ID: 33952237 [TBL] [Abstract][Full Text] [Related]
15. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis]. Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520 [TBL] [Abstract][Full Text] [Related]
16. Neutralization of IL-18 by IL-18 binding protein ameliorates bleomycin-induced pulmonary fibrosis via inhibition of epithelial-mesenchymal transition. Zhang LM; Zhang Y; Fei C; Zhang J; Wang L; Yi ZW; Gao G Biochem Biophys Res Commun; 2019 Jan; 508(2):660-666. PubMed ID: 30527805 [TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition. Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951 [TBL] [Abstract][Full Text] [Related]